Your browser doesn't support javascript.
loading
Safety and Tolerability of Fremanezumab for the Prevention of Migraine: A Pooled Analysis of Phases 2b and 3 Clinical Trials.
Silberstein, Stephen D; McAllister, Peter; Ning, Xiaoping; Faulhaber, Nicola; Lang, Nicole; Yeung, Paul; Schiemann, Jimmy; Aycardi, Ernesto; Cohen, Joshua M; Janka, Lindsay; Yang, Ronghua.
Afiliação
  • Silberstein SD; Jefferson Headache Center, Thomas Jefferson University, Philadelphia, PA, USA.
  • McAllister P; New England Institute for Neurology and Headache, Stamford, CT, USA.
  • Ning X; Teva Pharmaceuticals, Frazer, PA, USA.
  • Faulhaber N; Ratiopharm GmbH, Ulm, Germany.
  • Lang N; Ratiopharm GmbH, Ulm, Germany.
  • Yeung P; Teva Pharmaceuticals, Frazer, PA, USA.
  • Schiemann J; Teva Pharmaceuticals, Frazer, PA, USA.
  • Aycardi E; Teva Pharmaceuticals, Frazer, PA, USA.
  • Cohen JM; Teva Pharmaceuticals, Frazer, PA, USA.
  • Janka L; Teva Pharmaceuticals, Frazer, PA, USA.
  • Yang R; Teva Pharmaceuticals, Frazer, PA, USA.
Headache ; 59(6): 880-890, 2019 06.
Article em En | MEDLINE | ID: mdl-30977520
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies / Systematic_reviews Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies / Systematic_reviews Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article